Lithium succinate
 | |
| Clinical data | |
|---|---|
| Other names | Lithium succinate dibasic |
| AHFS/Drugs.com | Monograph |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| ECHA InfoCard | 100.163.153 |
| Chemical and physical data | |
| Formula | C4H4Li2O4 |
| Molar mass | 129.95 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Lithium succinate (C4H4Li2O4), the dilithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis[1] and proposed for the treatment of anogenital warts.[2]
References
[edit]- ^ Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology. 187 (2): 149–50. doi:10.1159/000247228. PMID 8358107.
- ^ Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International Journal of STD & AIDS. 8 (8): 515–7. doi:10.1258/0956462971920677. PMID 9259500. S2CID 23095115.
External links
[edit]- "Lithium succinate". Drug Information Portal. U.S. National Library of Medicine.
 | This dermatologic drug article is a stub. You can help Wikipedia by expanding it. |